Skip to content

Merck & Co. MRK Net Change in Cash

Net Change in Cash at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
-$635M-220%
Pfizer logo
PfizerPFE
$563M+50.1%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$1.98B-86.2%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
-$153.1M-125%
Cytokinetics logo
CytokineticsCYTK
$7.32M+135%
Phibro Animal Health logo
Phibro Animal HealthPAHC
-$557K+91.7%

Other financials

Income statement

See full
Revenue$16.3B+4.9%
Gross profit$12.1B-0.2%
Net income-$4.2B-183%
EPS (diluted)-$1.72-186%

Balance sheet

See full
Cash & equivalents$5.4B-38.2%
Total debt$49.1B+35.8%
Total equity$45.9B-5.1%
Total assets$128.69B+11.8%

Cash flow

See full
Operating cash flow$3.9B+56.7%
CapEx$991.0M-25.4%
Free cash flow$2.9B+150%

Valuation

See full
Market cap$317.77B+57.6%
Enterprise value$361.47B+56.9%
P/E35.6×+23.3×
P/S4.8×+1.7×

Profitability

See full
Gross margin73.9%-2.5pp
Net margin13.6%-13.7pp
FCF margin21.5%-5.2pp

Returns & leverage

See full
Return on equity19%-20.3pp
Debt / equity1.1×+0.3×
Current ratio1.3×-0.1×

Where this comes from

Reported directly by Merck & Co. in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: Merck & Co.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Merck & Co.'s net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Merck & Co.'s net change in cash?
Merck & Co. (MRK) reported net change in cash of -$9.29B in Q1 2026.
How has Merck & Co.'s net change in cash changed year-over-year?
Merck & Co.'s net change in cash decreased by 102.6% year-over-year, from -$4.59B to -$9.29B.
What does net change in cash mean?
Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.